ÂÜÀòÂÒÂ×

Mark King is an accomplished professional in the pharmaceutical industry, currently serving as Associate Director Quality at JensonR+ Limited since September 2022, specializing in GMDP consultancy and EU QP provision. Prior to this role, Mark held prominent positions at the Royal Society of Biology, including Vice Chair and Chair, overseeing quality assessments and strategic recommendations. Mark's extensive experience encompasses senior leadership roles at Accord Healthcare and Actavis, where responsibilities included quality operations, supplier quality management, and compliance with regulatory standards. Additionally, Mark has been influential in quality forums and initiatives, focusing on the integrity of generic medicines in the UK, and possesses a strong academic background with a BSc (Hons) in Applied Biology from Nottingham Trent University.